| abstract |
The invention discloses a forsythoside A drug composite, which contains forsythoside A and oleaginous base plant extract, wherein, the mass ratio of forsythoside A to oleaginous base and/or oleaginous base plant extract is 0.05:10-0.5:10. The forsythoside A drug composite can be well absorbed in gastrointestinal tracts, can acquire higher blood concentration, and has high oral bioavailability. |